These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 18656619)

  • 1. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society.
    Kitagami H; Kondo S; Hirano S; Kawakami H; Egawa S; Tanaka M
    Pancreas; 2007 Jul; 35(1):42-6. PubMed ID: 17575544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y; Davila J; Naumann C; El-Serag H
    Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors influencing results of the surgical treatment of pancreatic cancer].
    Ignashov AM; Kokhanenko NIu; Lisochkin BG; Savrasov VM; Volkov ON; Dvorakovskaia IV; Lebedev EG; Kulikov IuV
    Vestn Khir Im I I Grek; 2001; 160(1):33-6. PubMed ID: 11258321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States).
    Cress RD; Yin D; Clarke L; Bold R; Holly EA
    Cancer Causes Control; 2006 May; 17(4):403-9. PubMed ID: 16596292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
    Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
    Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
    Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
    J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
    Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
    Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease?
    Hartwig W; Denneberg M; Bergmann F; Hackert T; Hinz U; Strobel O; Büchler MW; Werner J
    Am J Surg; 2011 Jul; 202(1):23-7. PubMed ID: 21440887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
    McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
    Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreas.
    Meszoely IM; Lee JS; Watson JC; Meyers M; Wang H; Hoffman JP
    Am Surg; 2004 Mar; 70(3):208-13; discussion 213-4. PubMed ID: 15055843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
    Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
    Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of islet cell carcinoma.
    Yao JC; Eisner MP; Leary C; Dagohoy C; Phan A; Rashid A; Hassan M; Evans DB
    Ann Surg Oncol; 2007 Dec; 14(12):3492-500. PubMed ID: 17896148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
    Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
    Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.
    Hellan M; Sun CL; Artinyan A; Mojica-Manosa P; Bhatia S; Ellenhorn JD; Kim J
    Pancreas; 2008 Jul; 37(1):19-24. PubMed ID: 18580439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective.
    Nathan H; Wolfgang CL; Edil BH; Choti MA; Herman JM; Schulick RD; Cameron JL; Pawlik TM
    J Surg Oncol; 2009 Feb; 99(2):87-92. PubMed ID: 19021191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.